ArticleAmerican journal of translational research2018
FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.
Fengping Pan et al.PubMed ↗Full text ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it